Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Nov 13, 2025
SCHEDULE 13G Nov 12, 2025
10-Q Nov 5, 2025 10-Q
8-K Nov 5, 2025 8-K
SCHEDULE 13G/A Nov 5, 2025
8-K Nov 3, 2025 8-K
8-K Oct 16, 2025 8-K
4 Oct 3, 2025 4
4 Sep 25, 2025 4
4 Sep 25, 2025 4
SCHEDULE 13D/A Sep 15, 2025
SCHEDULE 13G Sep 12, 2025
4 Sep 11, 2025 4
8-K Sep 11, 2025 8-K
424B5 Sep 11, 2025 424B5
144 Sep 9, 2025
424B5 Sep 8, 2025 424B5
8-K Sep 8, 2025 8-K
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
10-Q Aug 7, 2025 10-Q
8-K Aug 7, 2025 8-K
4 May 22, 2025 4
← Newer Page 5 of 27 · 659 filings Older →